Jobs / United States / Glaxosmithkline LLC
Senior Director, Automation Acceleration Hub
Glaxosmithkline LLC · 🇺🇸 5 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles4 certified filings for “Associate Director – Genomic Technologies” (Molecular and Cellular Biologists) in PA: $134k–$138k, median $136k. Most were filed at wage level IV (50%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges. Senior Director, Automation Acceleration Hub GSK is seeking a visionary engineering leader to build and lead our newly formed Automation Acceleration Hub, reporting directly to the CTO. This global organization of approximately 50 professionals across the US, UK, and India will serve as the engine behind GSK's AI, automation, and platform engineering strategy. You will bring together AI Engineering, Intelligent Automation (RPA), and DevSecOps Platforms into one high-performing delivery organization that accelerates innovation, enables enterprise scale, and delivers measurable business outcomes across research, development, manufacturing, and commercial operations. This is a rare opportunity to shape how AI is built, governed, and deployed across one of the world's leading healthcare companies. What You'll Do: Lead the CTO's AI Transformation Agenda • Translate enterprise AI strategy into measurable business outcomes. • Drive execution across AI engineering, automation, and platform teams. • Manage portfolio prioritization, investment decisions, delivery governance, and value realization. Build and Scale Enterprise AI Capabilities • Lead the development and deployment of AI solutions, agents, and automation platforms. • Establish enterprise standards, reusable architectures, and AI-first engineering practices. • Accelerate adoption of AI across the technology organization through enablement, education, and best practices. Own the Automation & Platform Ecosystem • Lead GSK's enterprise RPA and intelligent automation capabilities. • Own DevSecOps platforms, CI/CD, developer experience, security, compliance, and operational excellence. • Drive convergence of traditional automation, AI, and platform engineering into a scalable operating model. Govern AI Responsibly • Establish trusted, compliant, and scalable AI governance frameworks. • Partner with Security, Legal, Privacy, Quality, and Compliance teams to ensure safe deployment in regulated environments. • Champion Responsible AI principles, operational resilience, and enterprise risk management. Inspire and Develop High-Performing Teams • Lead and grow a global team across AI Engineering, Automation, and Platform Engineering. • Influence executive stakeholders and technology leaders across the enterprise. • Represent GSK externally with strategic partners, technology providers, and industry forums. Basic Qualifications • 12+ years of progressive technology leadership experience, with at least 5 years leading enterprise AI engineering, platform engineering, DevOps/DevSecOps, or intelligent automation organizations at the SERNIOR DIRECTOR or equivalent level. • Demonstrated ownership of enterprise AI and automation delivery — designing, building, and deploying solutions at global scale with measurable business impact. • Deep, current subject matter expertise in modern AI architecture and engineering — LLMs, generative AI, agentic systems, classical ML, and the supporting MLOps/LLMOps tool ecosystem. • Proven experience